Nagashima, K., Lopez, C., Donovan, D., Ngai, C., Fontanez, N., Bensadoun, A., . . . Ginsberg, H. N. (2005). Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. American Society for Clinical Investigation.
Citação norma ChicagoNagashima, Kazunori, et al. Effects of the PPARγ Agonist Pioglitazone On Lipoprotein Metabolism in Patients With Type 2 Diabetes Mellitus. American Society for Clinical Investigation, 2005.
Citação norma MLANagashima, Kazunori, et al. Effects of the PPARγ Agonist Pioglitazone On Lipoprotein Metabolism in Patients With Type 2 Diabetes Mellitus. American Society for Clinical Investigation, 2005.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.